The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Flashback: That Time Corey Feldman Warned The View About Hollywood Child Sex Abuse and Was Scolded for It
Nancy Mace proposes bill to make aliens deportable, inadmissible for animal cruelty
WaPo Eats Crow For Reporting White House Didn’t Announce Something Trump Literally Put On Truth Social
DOJ antitrust shake-up reflects effort to define ‘MAGA antitrust’ after Slater exit
Partial government shutdown drags on as DHS funding talks stall
Ken Paxton sues Dallas over alleged failure to fund police as required by Proposition U
Burglary theory in missing Guthrie case ‘ridiculously rare’ says law enforcement source
New Mexico mother accused of drowning newborn in portable toilet after giving birth
California mom convicted after son dies in hot car while mother got lip fillers: ‘Defendant chose her looks’
Department of War transports next-generation reactor in nuclear energy milestone
Schumer says Dems will fight voter ID push ‘tooth and nail,’ balks at DHS role in elections
Hillary Clinton clashes with Czech leader over Trump policies at Munich security conference
Woman allegedly steals bus from elementary school parking lot, goes on late night ride
The one sentence in Rubio’s Munich speech that revealed Trump’s red line for Europe
Campus Radicals Newsletter: Antifa-linked group tells students to mobilize, college students fake disabilities
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Flashback: That Time Corey Feldman Warned The View About Hollywood Child Sex Abuse and Was Scolded for It
Nancy Mace proposes bill to make aliens deportable, inadmissible for animal cruelty
WaPo Eats Crow For Reporting White House Didn’t Announce Something Trump Literally Put On Truth Social
DOJ antitrust shake-up reflects effort to define ‘MAGA antitrust’ after Slater exit
Partial government shutdown drags on as DHS funding talks stall
Ken Paxton sues Dallas over alleged failure to fund police as required by Proposition U
Burglary theory in missing Guthrie case ‘ridiculously rare’ says law enforcement source
New Mexico mother accused of drowning newborn in portable toilet after giving birth
California mom convicted after son dies in hot car while mother got lip fillers: ‘Defendant chose her looks’
Department of War transports next-generation reactor in nuclear energy milestone
Schumer says Dems will fight voter ID push ‘tooth and nail,’ balks at DHS role in elections
Hillary Clinton clashes with Czech leader over Trump policies at Munich security conference
Woman allegedly steals bus from elementary school parking lot, goes on late night ride
The one sentence in Rubio’s Munich speech that revealed Trump’s red line for Europe
Campus Radicals Newsletter: Antifa-linked group tells students to mobilize, college students fake disabilities
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
